| SUBSCRIPTIONS |
|
|
|
DTCNews Subscription
|
|
|
 |
|
| We accept |
|
 |
|
 |
|
| Vacacionar Travel S.A. use Credit du Nord as a guarantee of absolute security in credit card transactions. |
|
 |
|
 |
|
|
|
|
|
|
 |
:
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
Cuba to Increase Production of Drug against Chronic Hepatitis C |
|
|
Monday, October 27, 2014
Havana.- Cuba's pharmaceutical industry will increase production of the drug known as PEG-Heberon, which is administered to patients suffering from chronic hepatitis C.
The said drug, which was developed at the Havana-based Genetic Engineering and Biotechnology Center, is expected to meet the total demand from the country's healthcare system.
PEG-Heberon is the commercial name of Interferon Alfa-2b, a drug that has similar properties to other products of its kind that are commercialized in the world to treat chronic hepatitis C mainly.
In December 2009, the drug was registered by the Center for the State Control of Medications, Equipment and Medical Devices.
In order to treat chronic hepatitis C, the subcutaneous injection of a vial of PEG-Heberon every week is combined with the daily oral administration of the antiviral drug Ribavirina.
|
|
|
|
|
|
|
|
|
|